Emerging research has highlighted the significant role of the microbiome in cancer development and response to treatment. Studies have shown that the composition of the gut microbiota can influence the efficacy of immunotherapy and chemotherapy. For instance, certain bacterial species have been found to enhance the immune system's ability to attack cancer cells, while others may promote cancer progression. Understanding the complex interactions between the microbiome and cancer could lead to novel therapeutic strategies, such as probiotics or microbiome-modulating drugs, to improve patient outcomes.
